Cortical lesions uniquely predict motor disability accrual and form rarely in the absence of new white matter lesions in multiple sclerosis
Beck, E. S.; Mullins, W. A.; Silva, J. d. S.; Filippini, S.; Parvathaneni, P.; Maranzano, J.; Morrison, M.; Suto, D. J.; Donnay, C.; Diekhaus, H.; Luciano, N. J.; Sharma, K.; Gaitan, M. I.; Liu, J.; de Zwart, J. A.; van Gelderen, P.; Cortese, I.; Narayanan, S.; Duyn, J. H.; Nair, G.; Sati, P.; Reich, D. S.
Show abstract
Background and objectivesCortical lesions (CL) are common in multiple sclerosis (MS) and associate with disability and progressive disease. We asked whether CL continue to form in people with stable white matter lesions (WML) and whether the association of CL with worsening disability relates to pre-existing or new CL. MethodsA cohort of adults with MS were evaluated annually with 7 tesla (T) brain magnetic resonance imaging (MRI) and 3T brain and spine MRI for 2 years, and clinical assessments for 3 years. CL were identified on 7T images at each timepoint. WML and brain tissue segmentation were performed using 3T images at baseline and year 2. Results59 adults with MS had [≥]1 7T follow-up visit (mean follow-up time 2{+/-}0.5 years). 9 had "active" relapsing-remitting MS (RRMS), defined as new WML in the year prior to enrollment. Of the remaining 50, 33 had "stable" RRMS, 14 secondary progressive MS (SPMS), and 3 primary progressive MS. 16 total new CL formed in the active RRMS group (median 1, range 0-10), 7 in the stable RRMS group (median 0, range 0-5), and 4 in the progressive MS group (median 0, range 0-1) (p=0.006, stable RR vs PMS p=0.88). New CL were not associated with greater change in any individual disability measure or in a composite measure of disability worsening (worsening Expanded Disability Status Scale or 9-hole peg test or 25-foot timed walk). Baseline CL volume was higher in people with worsening disability (median 1010l, range 13-9888 vs median 267l, range 0-3539, p=0.001, adjusted for age and sex) and in individuals with RRMS who subsequently transitioned to SPMS (median 2183l, range 270-9888 vs median 321l, range 0-6392 in those who remained RRMS, p=0.01, adjusted for age and sex). Baseline WML volume was not associated with worsening disability or transition from RRMS to SPMS. DiscussionCL formation is rare in people with stable WML, even in those with worsening disability. CL but not WML burden predicts future worsening of disability, suggesting that the relationship between CL and disability progression is related to long-term effects of lesions that form in the earlier stages of disease, rather than to ongoing lesion formation.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS 98%
- Paramagnetic rim lesions are associated with pathogenic CSF profiles and worse clinical outcomes in multiple sclerosis: a retrospective cross-sectional study 97%
- Glymphatic dysfunction in multiple sclerosis and its association with disease pathology and disability 96%
Similar papers in this journal
- Linking cortical lesions to metabolic changes in multiple sclerosis using 7T proton MR spectroscopy 96%
- Boston criteria v2.0 for cerebral amyloid angiopathy without hemorrhage: An MRI-neuropathological validation study 93%
- Exploring the Role of Plasma Lipids and Statins Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study 92%
Similar papers in this journal
Similar papers in this journal
- Alpha-Linolenic Acid Associations with Disability and Brain Volume in Multiple Sclerosis: A Brief Replication Report 95%
- Current status and future opportunities in modeling Multiple Sclerosis clinical characteristics 94%
- The Canadian Collaborative Project on Genetic Susceptibility to Multiple Sclerosis cohort population structure and disease etiology 93%
Similar papers in this journal
- A novel mouse model of cerebral adrenoleukodystrophy highlights NLRP3 activity in lesion pathogenesis 92%
- Cellular and humoral immunity to SARS-CoV-2 infection in multiple sclerosis patients on ocrelizumab and other disease-modifying therapies: a multi-ethnic observational study 91%
- SARS-CoV-2 third vaccine immune response in MS patients treated with ocrelizumab 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.